Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
140.5 USD | +0.77% | -0.05% | +6.62% |
May. 28 | Neurocrine Biosciences Says CEO Kevin Gorman Retiring | MT |
May. 28 | Neurocrine founder-CEO Gorman to retire in October | RE |
Chart: Technical Analysis
Technical analysis trends
Short Term | Mid-Term | Long Term | |
---|---|---|---|
Trend | Neutral | Bullish | Bullish |
Resistance | 143.74 | 143.74 | 142.29 |
Spread/Res. | -2.27% | -2.27% | -1.27% |
Spread/Supp. | +7.73% | +7.73% | +20.16% |
Support | 130.40 | 130.40 | 116.91 |
Technical Rankings Surperformance
Short Term Timing | |
---|---|
Middle Term Timing | |
Long Term Timing | |
RSI | |
Bollinger Spread | |
Unusual Volumes |
- Stock Market
- Equities
- NBIX Stock
- Charts Neurocrine Biosciences, Inc.